Skip to main content

Together we are beating cancer

Donate now

Cancer News

Cancer type

Showing 12 out of 2912 results

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research. In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

by Cancer Research UK | Analysis | 14 November 2022

14 November 2022

This entry is part 7 of 17 in the series Research Integrity
%postcontent%
Breast cancer cell seen through a scanning electron microscope

The "potentially life-saving" immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales. The "potentially life-saving" immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.

by Tim Gunn | News | 14 November 2022

14 November 2022

Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.  Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx. 

by Kathryn Thompson | News | 9 November 2022

9 November 2022

Professor Carolyn Bertozzi with graduate student Mireille Kamariza

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children. Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children.

by Tim Gunn | Analysis | 8 November 2022

8 November 2022

This entry is part 1 of 10 in the series Diversity in research
%postcontent%
Tissue stain of medulloblastoma - which is densely cellular and discrete from other tissue

Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future. Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.

by Lilly Matson | Analysis | 4 November 2022

4 November 2022

The House of Parliament in London

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

by Jacob Smith | Analysis | 1 November 2022

1 November 2022

A 3D illustration of cancer cells

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

by Jacob Smith | Analysis | 18 October 2022

18 October 2022

A graphic depicting a shadow in the shape of DNA overlaying strings of genetic code

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.   A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.  

by Jacob Smith | Analysis | 12 October 2022

12 October 2022